newsfilter
← Latest News
GlobeNewswire·

Wolf Popper LLP Announces Investigation on Behalf of BillionToOne, Inc. Investors

  • Wolf Popper LLP is investigating potential securities claims on behalf of purchasers of BillionToOne, Inc. (NASDAQ: BLLN) common stock.
  • BillionToOne, which provides genetic testing, conducted its initial public offering on November 5, 2025, at $60.00 per share.
  • On November 18, 2026, short seller Fuzzy Panda Research published a report alleging undisclosed fraudulent billing, a deductible capping scheme, and oncology hype.
  • The report claims the company has not disclosed that Tennessee is investigating it for Medicaid fraud.
  • Allegations include billing insurers for unnecessary tests for pregnant women, reducing or eliminating deductibles & copays to drive usage, overpaying doctors for blood draws, & providing free phlebotomists who perform unrelated work.
  • Following the report, BillionToOne's stock price fell $5.96 per share to $91.54, representing a 6.1% decline on heavy volume.
  • Investors seeking to discuss the investigation should contact Adam Savett at (212) 451-9655 or via email at asavett@wolfpopper.com.
Company
Wolf Popper LLP
Keywords
Wolf Popper LLP, CLASS ACTION LAWSUIT, LAW, LEGAL, securities, Class Action